Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Conditions

Fatigue 7Neoplasms 3Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pain 1Neurofibromatosis 1 1Multiple Endocrine Neoplasia Type 1 1Mental Disorders 1Depression 1Caregiver Burden 1Brain Neoplasms 1

Interventions

Fentanyl 19Analgesia 15Acupuncture Therapy 13Oxycodone 12Zoledronic Acid 11Surveys and Questionnaires 10nabiximols 9Therapeutics 9Morphine 9Acetaminophen 9Psychiatric Rehabilitation 8Ketamine 8Hydromorphone 7Lidocaine 6Ibandronic Acid 6Radiotherapy 5Early Intervention, Educational 5Bupivacaine 5Analgesics, Opioid 5Yoga 4Transcutaneous Electric Nerve Stimulation 4Therapeutic Touch 4Ropivacaine 4Music Therapy 4Methadone 4Massage 4Aromatherapy 4alvimopan 3Tapentadol 3Saline Solution 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Pain × Methylphenidate × Clear all
NCT00129467 2015-04-24

Methylphenidate for Depressed Cancer Patients Receiving Palliative Care

VA Office of Research and Development

Phase NA Completed
47 enrolled 13 charts

Caregiver Burden, Mental Disorders, Depression, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡